Drug Profile


Alternative Names: Acamprosate calcium; Alcomed; Aotal; Calcium acetylhomotaurinate; Campral; Campral EC; NS-11; Regtect; Sobriol; Zulex

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Laboratoires Meram
  • Developer Merck Lipha Sante; Nippon Shinyaku
  • Class Alkanesulfonic-acids; Drug withdrawal therapies; Small molecules
  • Mechanism of Action GABA receptor agonists; Glutamate receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Alcoholism

Most Recent Events

  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 27 May 2013 Launched for Alcoholism in Japan (PO)
  • 25 Mar 2013 Registered for Alcoholism in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top